2009
DOI: 10.1016/j.ejca.2009.07.024
|View full text |Cite
|
Sign up to set email alerts
|

What’s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
22
0
1

Year Published

2009
2009
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 41 publications
0
22
0
1
Order By: Relevance
“…Their consistent and proper use is the best available means for effectively preventing sexual transmission of viral and bacterial infections ranging from HIV and HPV, an oncogenic virus, to Chlamydia and gonorrhea [1], [2], [3]. Studies on condom use are often limited to specific subgroups such as students, sex workers or abortion seekers.…”
Section: Introductionmentioning
confidence: 99%
“…Their consistent and proper use is the best available means for effectively preventing sexual transmission of viral and bacterial infections ranging from HIV and HPV, an oncogenic virus, to Chlamydia and gonorrhea [1], [2], [3]. Studies on condom use are often limited to specific subgroups such as students, sex workers or abortion seekers.…”
Section: Introductionmentioning
confidence: 99%
“…Worldwide, the Pap test is still used by the majority of cervical cancer screening programs as the primary laboratorial tool of prevention. The conventional Pap smear has a winning history on decreasing the incidence of and mortality from cervical cancer, with an estimated reduction of around 80%, but this is restricted to settings with high-quality cytology screening that is effectively and regularly executed, with a good population coverage [4]. The conventional Pap smear, however, is quite laborious, with various difficulties concerning collection, the preparation of glass slides and reading.…”
Section: Introductionmentioning
confidence: 99%
“…For example, secondary prevention with screening for cervical cancer in asymptomatic females is quite successful [2], while the effect of secondary prevention of prostate cancer remains debated [3]. With the current lack of disease-modifying AD therapy, few strong arguments favour early AD diagnosis in clinical routine, although this could change within a foreseeable future.…”
Section: Introductionmentioning
confidence: 99%